These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2418266)

  • 1. [Microtitration method for determining von Willebrand's factor in the plasma of acute myocardial infarct patients].
    Bespal'ko IA
    Lab Delo; 1985; (12):718-22. PubMed ID: 2418266
    [No Abstract]   [Full Text] [Related]  

  • 2. [Elevated levels of plasma von Willebrand factor: a new risk factor for atherosclerosis?].
    Belicová M; Kubisz P; Kicko V; Dvorský J; Funiak S; Kvĕtenský J; Ivanková J
    Vnitr Lek; 1994 Oct; 40(10):660-2. PubMed ID: 7810085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma level of von Willebrand factor in patients with ischemic heart disease].
    Orlov VN; Vasil'eva EIu; Bespal'ko IA
    Ter Arkh; 1986; 58(3):57-60. PubMed ID: 3487128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract]   [Full Text] [Related]  

  • 5. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J; Tran-Thang C; Bachmann F
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1773-5. PubMed ID: 3879003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in von Willebrand's disease.
    Ruggeri ZM; Zimmerman TS
    Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative determination of the biological activity of Willebrand's factor].
    Baluda VP; Deianov I; Baluda MV; Liubina LV; Tlepshukov IK
    Lab Delo; 1988; (4):32-5. PubMed ID: 2457738
    [No Abstract]   [Full Text] [Related]  

  • 11. [Platelet aggregation and von Willebrand's factor in 32 insulin-dependent diabetics. Value of the measurement of filtration pressure in the presence of ADP].
    Prost-Dvojakovic RJ; Lecrubier C; Lanoe R; Batchvarova V; Samama M
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():239-47. PubMed ID: 1087675
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Von Willebrand factor and the antiaggregation activity of the vascular wall in diabetics].
    Sokolov EI; Baluda MV; Baluda VP; Balabolkin MI; Novikova IV; Deianov II; Timofeeva AV
    Ter Arkh; 1991; 63(4):104-5. PubMed ID: 1648796
    [No Abstract]   [Full Text] [Related]  

  • 16. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
    Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
    Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the von Willebrand factor].
    Turek P; Sikorová J; Vorlová Z
    Vnitr Lek; 1984 Jun; 30(6):550-6. PubMed ID: 6332414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.